Apomorphine is a medication derived from morphine. It works by stimulating dopamine receptors in the brain. It's known to cause strong nausea and vomiting, so it's sometimes used to treat severe poisoning. It has also been used to help manage symptoms of Parkinson's disease, but its side effects make it less common.
Every report comes from a Lived member, sent anonymously.
Have you tried Apomorphine for Parkinson's Disease?
Apomorphine is a prescription medicine for people with advanced Parkinson's disease whose usual treatment no longer controls symptoms smoothly through the day. As the disease progresses, a dose of levodopa (the main Parkinson's medicine) may wear off before the next one is due, or symptoms may return without warning. These "off" episodes bring back slowness, stiffness, tremor and difficulty walking or speaking. In the US, apomorphine comes in two forms with different jobs. Apokyn, also available as generic apomorphine injection, is a pen used to inject a single dose under the skin when an off episode begins, as a rescue treatment. Onapgo is a continuous infusion from a small wearable pump, approved for adults with advanced Parkinson's whose motor fluctuations (swings between good and poor movement control) call for steadier, all-day treatment. Both are used alongside levodopa and other Parkinson's medicines rather than replacing them. A film that dissolves under the tongue, Kynmobi, was once available but has been discontinued in the US.
Parkinson's disease develops when nerve cells in the brain do not produce enough dopamine, a chemical messenger needed for smooth, controlled movement. Apomorphine is a dopamine agonist: rather than adding more dopamine, it acts directly on the brain's dopamine receptors in place of the missing messenger. Its benefit is thought to come mainly from stimulating D2-type dopamine receptors in the brain areas that coordinate movement, though the exact mechanism is not fully understood. Because it is given under the skin rather than swallowed, apomorphine is absorbed quickly, reaching its peak level in the blood within about 10 to 60 minutes. That speed is what lets a pen injection cut short an off episode. The infusion uses the same drug differently, supplying it steadily through the waking day to smooth out the highs and lows between oral doses.
Apomorphine is injected under the skin (subcutaneously) and must never be injected into a vein, where it can form crystals that lead to blood clots, including clots in the lungs. Injection sites are rotated. With the Apokyn pen, the first dose is a test dose given in a clinic, where blood pressure and pulse are checked lying down and standing before the dose and for about an hour after. If it is tolerated and helps, the person or a trained caregiver then injects that dose at home at the start of an off episode. The pen is marked in milliliters (mL), not milligrams, so the prescription is written in mL to prevent mix-ups (0.1 mL contains 1 mg). The prescriber raises the dose gradually if needed; single doses above 0.6 mL (6 mg) are not recommended, and doses must be at least 2 hours apart. Keeping track of how much is left in each cartridge matters, because a nearly empty cartridge delivers only part of the dialed dose. Onapgo works differently. A thin tube (cannula) placed under the skin connects to a pump that delivers apomorphine continuously, usually over the waking day for up to 16 hours, with the option of small extra doses for breakthrough symptoms. The rate is started low and adjusted under medical supervision, and other Parkinson's medicines may be changed along the way. Onapgo is prescribed in milligrams per hour and is not interchangeable with pen doses. If the infusion has to stop for a long time, oral Parkinson's medicines are needed to cover the gap, so it helps to have that plan in advance. Because nausea is common at the start, prescribers often begin an anti-nausea medicine called trimethobenzamide three days before the first apomorphine dose. Another approach is to start apomorphine at a lower dose and build up slowly.
Nausea and vomiting are the best-known problems, especially in the first weeks, and can be severe. Trimethobenzamide helps early on but is usually continued for no more than about two months, because together with apomorphine it adds to sleepiness, dizziness and falls. Other common effects with the pen include yawning, drowsiness, light-headedness on standing, runny nose, swelling of the legs, hallucinations or confusion, and dyskinesia (involuntary writhing or jerking movements), which apomorphine can cause or worsen. With the infusion, firm lumps (nodules) and redness where the cannula sits are very common: more than four in ten people in the main study developed nodules. A red, warm, painful or swollen infusion site can mean infection and should be reported so the site can be changed. Some effects matter because people may not notice them in themselves. Apomorphine can cause sleepiness and, in some people, falling asleep suddenly during everyday activities such as eating or talking, sometimes without feeling drowsy first. Anyone who has fallen asleep this way should stop driving and contact the prescriber. Blood pressure can drop on standing, causing dizziness, fainting and falls; getting up slowly helps. Some people develop strong urges to gamble, spend, eat or pursue sex that they struggle to control. Family members are often the first to notice, and the prescriber should hear about it, since lowering the dose may help. New hallucinations, paranoia or confusion should also be reported. Less often, apomorphine causes serious problems. Palpitations (a pounding or irregular heartbeat) or fainting can signal a dangerous heart rhythm and should be reported to the prescriber promptly. Rarely, it destroys red blood cells (hemolytic anemia), which can show up as unusual tiredness or shortness of breath and should also be reported. An erection that is painful or will not go away needs immediate medical attention.
The most important interaction is with ondansetron, a widely used anti-nausea medicine, and related drugs in the same 5-HT3 blocker family (granisetron, dolasetron and palonosetron), as well as alosetron, a medicine for severe diarrhea-predominant irritable bowel syndrome. Ondansetron given with apomorphine has caused profound drops in blood pressure and loss of consciousness, so these combinations must not be used. It helps to tell every doctor, dentist and hospital team that you use apomorphine before any anti-nausea medicine is given. Several other anti-nausea and antipsychotic medicines that block dopamine, including prochlorperazine, promethazine, metoclopramide and haloperidol, can worsen Parkinson's symptoms and weaken apomorphine's effect. Alcohol, blood pressure medicines and nitroglycerin (a medicine dissolved under the tongue for chest pain) all add to apomorphine's blood-pressure-lowering effect. Alcohol is best avoided, and anyone who uses nitroglycerin should lie down before taking it and stay lying down afterward. Medicines that cause drowsiness add to the risk of sudden sleep. Apomorphine is not for people who have had an allergic reaction to it or who are sensitive to sulfites; it contains sodium metabisulfite, which can trigger severe allergic reactions or asthma attacks in sulfite-sensitive people. It is ordinarily avoided in people with a major psychotic disorder. It also needs care in people with heart or blood vessel disease: by lowering blood pressure it can reduce blood flow to the heart, and angina and heart attacks have occurred, sometimes within two hours of a dose. Apomorphine can lengthen the QT interval, a part of the heart's electrical cycle measured on an electrocardiogram (ECG), so the prescriber will review other medicines and conditions that affect heart rhythm.
Starting apomorphine takes some setup: a supervised first dose, training for the person and caregiver on the pen or pump, and a period of adjusting the dose. Nausea is usually worst at the beginning. In the pen studies, about half of people were able to stop trimethobenzamide, on average about two months in, while continuing apomorphine. A pen injection is meant to work quickly. In the original study, most people given apomorphine during an off episode reached a response similar to their usual levodopa dose at about 20 minutes. With the infusion, the aim is less off time overall. In the main 12-week study, people who started with about 6.7 hours of off time a day had about 2.5 fewer hours with the infusion, compared with about 0.9 fewer hours with placebo, and gained more good "on" time without troublesome dyskinesia. Responses vary, and some people find the injections, pump or side effects outweigh the benefit. Treatment is ongoing, with regular check-ins about blood pressure, sleepiness, mood and behavior, movement control and, for the infusion, the skin at the cannula sites. Apomorphine should not be stopped or sharply reduced without talking to the prescriber, because withdrawal from dopamine medicines can cause high fever and confusion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Apomorphine, what you've noticed, or ask the community a question.